Who is generally a candidate Adults 18 and older with a BMI of 30 or higher (obesity), or Adults with a BMI of 27 or higher plus at least one weight-related condition: type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea No disqualifying personal or family medical history (see below) Willing to attend an in-person evaluation and follow-up visits during titration Who we generally do not prescribe to Personal or family history of medullary thyroid carcinoma or MEN2 syndrome (multiple endocrine neoplasia type 2) History of pancreatitis Severe gastroparesis or other significant gastrointestinal motility disease Pregnancy , breastfeeding, or actively planning pregnancy An active eating disorder Known hypersensitivity to semaglutide, tirzepatide, or a formulation's inactive ingredients We also look at what else is driving your case before deciding a GLP-1 is the right tool

Its now also available as a daily pill and as a higher-dose injectable version, Wegovy HD 7.2 mg, all made by the company Novo Nordisk
Life Sciences, 80(4), 275-284
Gim tnh trng sm da do nh nng mt tri, tia Uv gy sm da
There is no structured nutrition or fitness program included
GLP-1 receptor agonists are a group of medications that mimic the natural GLP-1 hormone that is released in our body after consuming a meal